Suitability of Video Consultations During the COVID-19 Pandemic Lockdown: Cross-sectional Survey Among Norwegian General PractitionersOriginal Paper Published on 2021-02-082022-10-30 Journal: Journal of Medical Internet Research [Category] Coronavirus, MERS, [키워드] Anxiety asked association basic Care chi-square tests collected complex conducted consultation Contact Continuity of care COVID-19 COVID-19 pandemic cross-sectional demographic characteristics Depression digital consultations eHealth evaluate evaluated experiment Follow-up General practice general practitioner had no Health indicate knowledge life stress lockdown MOST Norway objective offered online survey pandemic Patient patient safety performed physician-patient relationship Practitioner Primary Health Care problem problems Result Safety survey telehealth Telemedicine the patient video consultations [DOI] 10.2196/26433 PMC 바로가기 [Article Type] Original Paper
Apremilast in Refractory Behçet’s Syndrome: A Multicenter Observational StudyOriginal Research Published on 2021-02-042024-09-02 Journal: Frontiers in immunology [Category] 대상포진, [키워드] apremilast Behçet Cohort Efficacy joint Safety skin [DOI] 10.3389/fimmu.2020.626792 PMC 바로가기 [Article Type] Original Research
COVID-19 Vaccine Acceptance among Health Care Workers in the United StatesArticle Published on 2021-02-032022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] acceptance Analysis black Care collected combating Complete conducted COVID-19 COVID-19 vaccination COVID-19 vaccine cross Direct Effectiveness female Final HCW HCWs healthcare worker Healthcare workers increasing age pandemic receive response Safety study population the United State the vaccine United States vaccination Vaccine widespread worker [DOI] 10.3390/vaccines9020119 PMC 바로가기 [Article Type] Article
Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main ProteasePharmacology Published on 2021-02-012022-10-31 Journal: Frontiers in Pharmacology [Category] COVID-19, [키워드] 3CL pro addition baseline Clinical data conserved COVID-19 COVID-19 pandemic COVID-19 therapeutics drug drugs targeting inhibitors inhibitors of SARS-CoV-2 M pro main protease maturation pharmacokinetic pharmacokinetics potency Potential profile protease Safe Safety SARS-CoV-2 targeting virus replication [DOI] 10.3389/fphar.2020.630500 PMC 바로가기 [Article Type] Pharmacology
Safety of nontumor necrosis factor-targeted biologics in the COVID-19 pandemicCOVID-19 대유행에서 비종양 괴사 인자 표적 생물학적 제제의 안전성Review Published on 2021-02-012022-09-11 Journal: Journal of medical virology [Category] Fulltext, MERS, 임상, 진단, [키워드] COVID-19 pandemic Necrosis Safety [DOI] 10.1002/jmv.26528 PMC 바로가기 [Article Type] Review
Humanized anti-CD19 chimeric antigen receptor-T cell therapy is safe and effective in lymphoma and leukemia patients with chronic and resolved hepatitis B virus infectionClinical Trial Published on 2021-02-012023-06-13 Journal: Hematological oncology [Category] B형 간염, [키워드] HBV reactivation humanized anti-CD19 CAR-T leukemia lymphoma Safety [DOI] 10.1002/hon.2807 PMC 바로가기 [Article Type] Clinical Trial
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial18~59세의 건강한 성인을 대상으로 한 비활성화된 SARS-CoV-2 백신의 안전성, 내약성 및 면역원성: 무작위 배정, 이중 맹검, 위약 대조, 1/2상 임상 시험Clinical Trial Published on 2021-02-012022-09-12 Journal: The Lancet. Infectious Diseases [Category] MERS, SARS, 임상, 진단, [키워드] 1:1 acute respiratory syndrome Adverse reaction allergic assigned axillary temperature Beijing Block randomisation Cell chamber China Chinese clinical trial Cohort cohorts Community Corning CoronaVac coronavirus COVID-19 COVID-19 pandemic development diluent dose dose-escalating manner double-blind Efficacy Endpoint enrolled FIVE healthy High-dose hydroxide immunogenic inactivated Inactivated vaccine incidence Infection injection investigated investigators Jiangsu Laboratory live SARS-CoV-2 low dose low-dose morbidity and mortality neutralising antibody nine outcome participant per-protocol population phase 1 trial phase 2 trial Phase 3 trials Placebo placebo-controlled produced Program randomisation randomised Randomly receive recruited Registered Safety safety population SARS-CoV-2 SARS-CoV-2 vaccine Science separated Seroconversion seroconversion rate Seven Sinovac Life Sciences study drug suggested Taking technology the placebo group Tolerability treatment allocation Trial vaccination vaccination schedule Vaccine was done were excluded were given [DOI] 10.1016/S1473-3099(20)30843-4 PMC 바로가기 [Article Type] Clinical Trial
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trialSARS-CoV-2 감염 치료를 위한 흡입 분무 인터페론 베타-1a(SNG001)의 안전성 및 효능: 무작위 배정, 이중 맹검, 위약 대조, 2상 시험Clinical Trial Published on 2021-02-012022-09-11 Journal: The Lancet. Respiratory Medicine [Category] 임상, 치료제, [키워드] 1:1 activities acute respiratory syndrome acute respiratory syndrome coronavirus adverse event adverse events Analysis assigned clinical clinical condition Clinical improvement clinical trials coronavirus COVID-19 symptoms death dose double-blind during treatment Efficacy Efficacy and safety FIVE greater hazard ratio headache hospital identify improvement Infection inhalation Inhaled Inpatient Inpatients intention-to-treat population interferon Interferon beta-1a MIU Multiple nine no infection Odds ratio Older Ordinal Scale oxygen oxygen supplementation Patient Phase 2 phase 2 trial Placebo placebo group placebo-controlled point-of-care positive RT-PCR Primary outcome randomised Randomly receive receiving Registered reported required respiratory Safety SARS-CoV-2 SARS-COV-2 infection scale Seven severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 statistical study drug substantial risk Symptoms the placebo group the WHO those receiving placebo Treatment treatment-emergent adverse event Trial trials WHO ordinal scale with COVID-19 [DOI] 10.1016/S2213-2600(20)30511-7 PMC 바로가기 [Article Type] Clinical Trial
Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: A phase 1/11 randomized control trial (SEOT study)Clinical Trial Published on 2021-02-012022-10-05 Journal: International immunopharmacology [Category] SARS, 임상, [키워드] accounted adverse event Anti-viral auto Care changes in Clinical features clinical status clinical symptom clinically control group Corona virus COVID-19 death demonstrated disease early recovery Efficacy facilitate group IMPROVE inflammatory markers Insufflation integrative medicine main outcome measure Mild moderate Moderate COVID-19 Mortality Oxygen therapy oxygenation index Ozone therapy pandemic parallel group parameter Patient polymerase chain profiles Randomized rectal reduce reported RT-PCR Safety SARS-CoV-2 shown ST group standard care Standard of care statistical significance tested the mean therapy Transcription Trial Viral load [DOI] 10.1016/j.intimp.2020.107301 PMC 바로가기 [Article Type] Clinical Trial
Telehealth in the COVID-19 Era: A Balancing Act to Avoid HarmViewpoint Published on 2021-02-012022-10-30 Journal: Journal of Medical Internet Research [Category] Coronavirus, MERS, [키워드] access Act adopted approach assist balancing Care Characteristics clinician coronavirus COVID-19 disease Efficiency Harm Health informatics limit limitation offer outcome Patient Patient care patient safety public health crisis Regulation risk Safety telehealth Virtual care [DOI] 10.2196/24785 PMC 바로가기 [Article Type] Viewpoint